243 related articles for article (PubMed ID: 26863638)
1. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.
Walther U; Emmrich K; Ramer R; Mittag N; Hinz B
Oncotarget; 2016 Mar; 7(9):10345-62. PubMed ID: 26863638
[TBL] [Abstract][Full Text] [Related]
2. Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.
Ramer R; Walther U; Borchert P; Laufer S; Linnebacher M; Hinz B
J Lipid Res; 2013 Nov; 54(11):3116-29. PubMed ID: 23943857
[TBL] [Abstract][Full Text] [Related]
3. COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells.
Ramer R; Heinemann K; Merkord J; Rohde H; Salamon A; Linnebacher M; Hinz B
Mol Cancer Ther; 2013 Jan; 12(1):69-82. PubMed ID: 23220503
[TBL] [Abstract][Full Text] [Related]
4. R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway.
Eichele K; Ramer R; Hinz B
Pharm Res; 2009 Feb; 26(2):346-55. PubMed ID: 19015962
[TBL] [Abstract][Full Text] [Related]
5. Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells.
Eichele K; Ramer R; Hinz B
Oncogene; 2008 May; 27(21):3032-44. PubMed ID: 18071320
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
[TBL] [Abstract][Full Text] [Related]
7. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
Taketa K; Matsumura T; Yano M; Ishii N; Senokuchi T; Motoshima H; Murata Y; Kim-Mitsuyama S; Kawada T; Itabe H; Takeya M; Nishikawa T; Tsuruzoe K; Araki E
J Biol Chem; 2008 Apr; 283(15):9852-62. PubMed ID: 18208815
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Kim KY; Ahn JH; Cheon HG
Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
[TBL] [Abstract][Full Text] [Related]
12. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
13. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
14. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
[TBL] [Abstract][Full Text] [Related]
15. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells.
Michael MS; Badr MZ; Badawi AF
Int J Mol Med; 2003 Jun; 11(6):733-6. PubMed ID: 12736714
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of COX-2 and activation of PPAR-γ resulted in the same level and pattern of neuroprotection as they were targeted separately.
Abraki SB; Khalaj L; Shaerzadeh F; Khodagholi F
J Mol Neurosci; 2013 Jan; 49(1):116-29. PubMed ID: 23132402
[TBL] [Abstract][Full Text] [Related]
19. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.
Planagumà A; Clària J; Miquel R; López-Parra M; Titos E; Masferrer JL; Arroyo V; Rodés J
FASEB J; 2005 Jul; 19(9):1120-2. PubMed ID: 15876570
[TBL] [Abstract][Full Text] [Related]
20. Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation.
Hsu CK; Lin CC; Hsiao LD; Yang CM
Br J Pharmacol; 2015 Nov; 172(22):5360-76. PubMed ID: 26359950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
